S. Adams

发表

The -590C/T and -34C/T interleukin-4 promoter polymorphisms are not associated with atopic eczema in childhood.

K. Elliott, G. Stewart, J. Brown, 2001, The Journal of allergy and clinical immunology.

Studies on Activities of Invariant Chain Peptides on Releasing or Exchanging of Antigenic Peptides at Human Leukocyte Antigen-DR1

M. Xu, Minzhen Xu, R. Humphreys, 1999, Arzneimittelforschung.

Increasing the potency of MHC class II-presented epitopes by linkage to Ii-Key peptide.

E. von Hofe, M. Xu, R. Humphreys, 2000, Vaccine.

Invriant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules

R. Humphreys, S. Adams, 1995 .

Sulfated polyanions prevent HIV infection of lymphocytes by disruption of the CD4‐gp120 interaction, but do not inhibit monocyte infection

A. Sloane, G. Lynch, C. Parish, 1994, Journal of leukocyte biology.

Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients

M. Atkins, J. Meer, J. Mier, 1988, Journal of Clinical Immunology.

Biological activity and therapeutic potential of homologs of an Ii peptide which regulates antigenic peptide binding to cell surface MHC class II molecules.

F. Albericio, E. Smith, R. Humphreys, 1997, Arzneimittel-Forschung.

Invariant chain peptides enhancing or inhibiting the presentation of antigenic peptides by major histocompatibility complex class II molecules.

R. Humphreys, S. Adams, 1995, European journal of immunology.

Bispecific monoclonal antibody regulation of Fc gamma RIII-directed tumor cytotoxicity by large granular lymphocytes.

L. Weiner, S. Adams, Ç. Gerçel-Taylor, 1992, Cellular immunology.

Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus

C. Mohan, S. Datta, S. Adams, 1993, The Journal of experimental medicine.

Comparison of actual and random-positioning-model distributions of peptide scavenging and T cell-presented sites in antigenic proteins.

R. Lew, M. Salomon, R. Humphreys, 1993, Vaccine.

Enhanced immunogenicity of a T cell immunogenic peptide by modifications of its N and C termini.

E. Unanue, P. Allen, J. Freeman, 1989, International immunology.